JP2023546125A5 - - Google Patents
Info
- Publication number
- JP2023546125A5 JP2023546125A5 JP2023523059A JP2023523059A JP2023546125A5 JP 2023546125 A5 JP2023546125 A5 JP 2023546125A5 JP 2023523059 A JP2023523059 A JP 2023523059A JP 2023523059 A JP2023523059 A JP 2023523059A JP 2023546125 A5 JP2023546125 A5 JP 2023546125A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- crystalline form
- crystal morphology
- ray powder
- powder diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020120814 | 2020-10-14 | ||
| CNPCT/CN2020/120814 | 2020-10-14 | ||
| PCT/CN2021/123387 WO2022078352A1 (en) | 2020-10-14 | 2021-10-13 | Crystal forms of glp-1r agonists and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023546125A JP2023546125A (ja) | 2023-11-01 |
| JP2023546125A5 true JP2023546125A5 (https=) | 2024-10-21 |
| JP7769695B2 JP7769695B2 (ja) | 2025-11-13 |
Family
ID=78401981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023523059A Active JP7769695B2 (ja) | 2020-10-14 | 2021-10-13 | Ｇｌｐ－１ｒアゴニストの結晶形態およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12516041B2 (https=) |
| EP (1) | EP4228753B1 (https=) |
| JP (1) | JP7769695B2 (https=) |
| CN (1) | CN116710446B (https=) |
| AU (1) | AU2021359493A1 (https=) |
| CA (1) | CA3195264A1 (https=) |
| ES (1) | ES3041328T3 (https=) |
| TW (1) | TWI912388B (https=) |
| WO (1) | WO2022078352A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114761395B (zh) * | 2019-12-02 | 2024-11-15 | 现代药品株式会社 | Glp-1受体激动剂 |
| PT4408840T (pt) | 2021-09-27 | 2025-10-07 | Terns Pharmaceuticals Inc | Ácidos benzimidazolocarboxílicos como agonistas de glp-1r |
| CN118401519A (zh) | 2021-10-25 | 2024-07-26 | 拓臻制药公司 | 作为glp-1r激动剂的化合物 |
| CN119095843A (zh) | 2022-02-23 | 2024-12-06 | 拓臻制药公司 | 作为glp-1r激动剂的化合物 |
| CN117362282B (zh) * | 2022-07-07 | 2026-04-21 | 杭州德睿智药科技有限公司 | Glp-1r激动剂的盐及其制备方法和应用 |
| US20260028332A1 (en) * | 2022-07-18 | 2026-01-29 | Mindrank Therapeutics (Suzhou) New Drug Research And Development Co., Ltd | Polymorphic form of glp-1r agonist, preparation method therefor and use thereof |
| EP4568664B1 (en) | 2023-04-07 | 2026-04-01 | Terns Pharmaceuticals, Inc. | Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity |
| CN120981457A (zh) | 2023-09-14 | 2025-11-18 | 歌礼制药(中国)有限公司 | Glp-1r激动剂及其治疗方法 |
| TW202521534A (zh) | 2023-11-24 | 2025-06-01 | 香港商歌禮製藥(中國)有限公司 | Glp-1r 激動劑及其治療方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| EA018225B1 (ru) | 2008-03-07 | 2013-06-28 | Транстек Фарма, Инк. | Соединения оксадиазоантрацена для лечения диабета |
| AR083878A1 (es) * | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| KR102314286B1 (ko) * | 2016-12-16 | 2021-10-21 | 화이자 인코포레이티드 | Glp-1 수용체 작용제 및 이의 용도 |
| DK3806855T5 (da) * | 2018-06-15 | 2023-05-22 | Pfizer | GLP-1-receptoragonister og anvendelser deraf |
| MA54555A (fr) * | 2018-11-22 | 2021-09-29 | Qilu Regor Therapeutics Inc | Agonistes de glp-1r et leurs utilisations |
| EP3953344A4 (en) * | 2019-04-12 | 2023-08-09 | Qilu Regor Therapeutics Inc. | GLP-IR AGONISTS AND THEIR USES |
-
2021
- 2021-10-13 CN CN202180082321.9A patent/CN116710446B/zh active Active
- 2021-10-13 US US18/031,380 patent/US12516041B2/en active Active
- 2021-10-13 JP JP2023523059A patent/JP7769695B2/ja active Active
- 2021-10-13 EP EP21798552.2A patent/EP4228753B1/en active Active
- 2021-10-13 CA CA3195264A patent/CA3195264A1/en active Pending
- 2021-10-13 TW TW110138006A patent/TWI912388B/zh active
- 2021-10-13 ES ES21798552T patent/ES3041328T3/es active Active
- 2021-10-13 WO PCT/CN2021/123387 patent/WO2022078352A1/en not_active Ceased
- 2021-10-13 AU AU2021359493A patent/AU2021359493A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023546125A5 (https=) | ||
| JP2021091683A5 (https=) | ||
| FI4157832T3 (fi) | Glp-1r-agonistien suola- ja kidemuotoja ja niiden käyttötarkoituksia | |
| TWI864650B (zh) | Glp-1受體激動劑化合物之新穎鹽類、其製備方法以及包含其之醫藥組合物 | |
| JP2025506474A5 (https=) | ||
| JP2021073256A5 (https=) | ||
| JP2009534373A (ja) | 新しい結晶形態のラミブジン | |
| WO2007079681A1 (en) | Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation | |
| CN117417330A (zh) | 一种glp-1r激动剂化合物的多晶型物及其制备方法与用途 | |
| US6610718B2 (en) | Processes for making- and a new crystalline form of- leflunomide | |
| EP4585593A1 (en) | Polymorph of glp-1r agonist compound, preparation method therefor, and use thereof | |
| CN117417329A (zh) | 一种glp-1r激动剂的多晶型物及其制备方法与用途 | |
| JP2009517353A (ja) | メシル酸イマチニブのｆ、ｇ、ｈ、ｉおよびｋ結晶形 | |
| JP2023530786A5 (https=) | ||
| JP4740875B2 (ja) | アムロジピンのゲンチシン酸塩及びその製造方法 | |
| US20260028332A1 (en) | Polymorphic form of glp-1r agonist, preparation method therefor and use thereof | |
| RU2023112071A (ru) | ТВЕРДЫЕ ФОРМЫ СОЛИ 2-((4-((S)-2-(5-ХЛОРПИРИДИН-2-ил)-2-МЕТИЛБЕНЗО[d][1,3]ДИОКСОЛ-4-ИЛ)ПИПЕРЕДИН-1-ИЛ)МЕТИЛ)-1-(((S)-ОКСЕТАН-2-ИЛ)МЕТИЛ)-1H-БЕНЗО[d]ИМИДАЗОЛ-6-КАРБОНОВОЙ КИСЛОТЫ С 1,3-ДИГИДРОКСИ-2-(ГИДРОКСИМЕТИЛ)ПРОПАН-2-АМИНОМ | |
| RU2024105013A (ru) | Твердые формы 2-[(4-{ 6-[(4-циано-2-фторбензил)окси]пиридин-2-ил} пиперидин-1-ил)метил]-1- [(2s)-оксетан-2-илметил]-1hбензимидазол-6-карбоновой кислоты, 1,3-дигидрокси-2- (гидроксиметил)пропан-2-аминной соли | |
| RU2025104879A (ru) | Полиморф соединения-агониста glp-1r, способ его получения и его применение | |
| JP2025511126A5 (https=) | ||
| JP2021134211A5 (https=) | ||
| EA051917B1 (ru) | Новая соль соединения-агониста рецептора гпп-1, способ ее получения и содержащая ее фармацевтическая композиция | |
| RU2025102482A (ru) | Соль агониста glp-1r, способ ее получения и ее применение | |
| HK40118695A (zh) | 一种glp-1r激动剂化合物的多晶型物及其制备方法与用途 | |
| HK40118695B (zh) | 一种glp-1r激动剂化合物的多晶型物及其制备方法与用途 |